> Présentation    > Les membres du Comité Directeur    > Dr Michel BRAZIER

Comité scientifique du GRIO

Dr Michel BRAZIER



Publications récentes
 
1- Serum IgA rheumatoid factor and pyridinoline in very-early arthritis are predictors of erosion(s) at 2 years: A simple model of prediction from the conservately treated community-based inception VErA cohort.
Le Loët X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, Pouplin S, Tron F, Zarnitsky C, Vittecoq O, Menard JF, Fardellone P.
Arthritis Care Res. 2010 Aug 25. [Epub ahead of print]

2- Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice.
Tyagi AM, Gautam AK, Kumar A, Srivastava K, Bhargavan B, Trivedi R, Saravanan S, Yadav DK, Singh N, Pollet C, Brazier M, Mentaverri R, Maurya R, Chattopadhyay N, Goel A, Singh D.
Mol Cell Endocrinol. 2010 Jun 4. [Epub ahead of print]

3- Strontium ranelate decreases RANKL-induced osteoclastic differentiation in vitro: involvement of the calcium sensing receptor.
Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, Petit L, Petit JP, Terwilliger E, Kamel S, Brown EM, Mentaverri R, Brazier M.
Mol Pharmacol. 2010 Jun 28. [Epub ahead of print]

4-The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
S Liabeuf, DV Barreto, FC Barreto, M Chasseraud, M Brazier, G Choukroun, S Kamel, Z A Massy.
Nephrol Dial Transplant. 2010 Feb 26. [Epub ahead of print]

5- Implication of the calcium sensing receptor and the phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells.
C Boudot, Z Saidak, AK Boulanouar, L Petit, F Gouilleux, Z Massy, M Brazier, R Mentaverri, S Kamel.
Bone. 2010 Feb 8. [Epub ahead of print]

6- Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
A Caudrillier, R Mentaverri, M Brazier, S Kamel, ZA Massy.
J Nephrol, 2010; 23 (1) : 17-22

7- Oligogalacturonic acid inhibit bone resorption and collagen degradation through its interaction with type I collagen.
JM Lion, R Mentaverri, S Rossard, N Jullian, B Courtois, J Courtois, M Brazier, JC Maziere, S Kamel.

> Présentation    > Les membres du Comité Directeur    > Dr Michel BRAZIER

Mme Patricia HALOUZE
Secrétariat du GRIO

Centre d'Évaluation des Maladies Osseuses
Hôpital COCHIN
27, rue du Faubourg Saint Jacques
75014 PARIS

Fax : 01.44.07.01.07

Dernière mise à jour : 01-12-2010
Mentions légales - © 2004-2012 GRIO
Rechercher     
Accueil    |    Plan du site    |    Contact